• Ready for Some Midyear Magic

    The RxStrategies team is ready for some midyear magic at the ASHP Midyear Conference being held December 2-6. At this prestigious conference – the largest global gathering of pharmacy professionals – RxStrategies team members Skip Devanny, Rhodie Smith and Jonathan Ghenn will network with more than 25,000 pharmacy professionals and discuss current trends, news and… Read more »

  • Clinical Insights: November 7, 2018

    Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place.   New Drug Approval Lorbrena® (lorlatinib) – New Drug Approval – November 2, 2018 – The Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with… Read more »

  • Intuitive Contract Pharmacy Management through Advanced Reporting and Analytics

    RxStrategies emphasizes a conservative approach to 340B contract pharmacy administration while maximizing program results. Our simple, all-inclusive fee ensures more of the 340B savings remain with the Covered Entity (CE). In addition, our audit-proven eligibility matching algorithm drives matches to qualify each individual transaction. Our 340B Contract Pharmacy Solution: Intuitive, Cloud-Based Platform: Provides unprecedented insights into… Read more »

  • Celebrating National Health Center Week!

    According to NACHC, health centers currently serve 27 million patients. This year, National Health Center Week will be recognized on August 12-18. Our team at RxStrategies is appreciative of the many health centers dedicated to providing affordable quality care to their communities. We are honored to be able to support your mission and vision by… Read more »

  • Integrated Solutions to Maintain Program Compliance

    There are many challenges organizations face when maintaining a compliant 340B Drug Pricing Program. At RxStrategies, we specialize in delivering integrated solutions to assist implementation and compliance.   Split Billing Provides end-to-end 340B program management and addresses its complexity by reviewing all prescription activity to flag eligible 340B dispenses.   CompliancePlus Streamlines workflow, quickly indemnifies… Read more »

  • Maintain a Compliant 340B Program in Your Hospital

    Through RxStrategies’ hospital-focused services, hospitals can manage and track grant funded subsidies, manage 340B product purchases and inventory, participate in P&T committees, manage pharmacies, receive consulting services to improve financial, operational and strategic management and more. The comprehensive solutions that allow hospitals to maintain a compliant 340B program include: Split Billing – Addresses the complexity… Read more »

  • Ensure and Maximize 340B Program Compliance

    We assist retail and specialty pharmacies in ensuring 340B program security, efficiency and safety. With this solution, you will be able to maximize compliance, visibility, capture rate, inventory reconciliation and more.   Key Elements of Our Enterprise Backbone for Retail and Specialty Pharmacies • Serves as data clearinghouse for all your contracted TPAs (Third Party… Read more »

  • RxStrategies is Orlando Bound!

    The RxStrategies team is gearing up for Orlando, Florida December 3-7 for the American Society of Health-System Pharmacists (ASHP) 2017 Midyear Conference. Learn more details about the Midyear Conference here > Our team will be connecting with industry leaders to gain insight and discuss the latest 340B Program developments during this highly attended conference.  … Read more »

  • Clinical Insights: June 16, 2017

    Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place.   New Drug Approval Fibryna® (fibrinogen – [human]) – June 7, 2017 – A human fibrinogen concentrate indicated for the treatment of acute bleeding episodes in adults and adolescents with congenital… Read more »

  • FQHCs

    Community Health Centers serve as the primary medical home for over 23 million people in 9,800 rural and urban communities across America. source: NACHC.org The 340B Drug Discount Program is an essential source of support for Community Health Centers, allowing them to stretch increasingly scarce federal resources and reinvest in patient care. Health centers report that 340B is integral to… Read more »